Sponsor:
Legend Labz, Inc.
Code:
NCT05494112
Conditions
Safety
Eligibility Criteria
Sex: All
Age: 18 - 40
Healthy Volunteers: Accepted
Interventions
Celastrol
Brief summary:
Conditions
Safety
Study ID
NCT05494112
Start date
May 25, 2022
Status verified date
Aug, 2022
Completion date
May 25, 2023
Anticipated
Primary completion date
May 25, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 40
Healthy Volunteers: Accepted
Enrollment
35 participants
Anticipated
Intervention Model
Sequential
Primary purpose
Basic Science
Arms
experimental: Amount of Celastrol Administered
Interventions
Celastrol
Primary outcome measure
Central contacts
Locations
Patient Plus Urgent Care
Recruiting
Baton Rouge, Louisiana, United States, 70810
Contacts
Principal Investigator:
Rubin Patel, MD
Sponsor
Legend Labz, Inc.
Last update posted
Aug 9, 2022
Last verified
Aug, 2022
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Legend Labz, Inc. on 2022-08-09.